| Roche CEO still optimistic on new breast cancer drug | | | VIENNA (Reuters) - Roche is convinced a new breast cancer drug will have a significant role in treating the disease despite recent trial results that disappointed analysts, the Swiss drugmaker's chief executive said in an interview published on Sunday. |
| |
| Chi-Med steps closer to Chinese pharma first with drug filing | | | LONDON (Reuters) - Hutchison China MediTech, the Shanghai-based drugmaker listed in London, is a step closer to winning approval for a modern drug developed in a Chinese lab with the submission of its cancer medicine fruquintinib to China's drug watchdog. |
| |
| Mars recalls some chocolates due to likely Salmonella presence | | | (Reuters) - Confectioner Mars Inc, owner of the Mars and M&M brands, said on Friday that it had voluntarily recalled some products sold under the Galaxy brand in the UK and Ireland as it detected the possible presence of Salmonella in the ingredients. |
| |
| AbbVie must pay $15 million in Depakote birth-defect trial: jury | | | (Reuters) - A federal jury on Friday awarded $15 million to a 10-year-old boy whose mother blamed his birth defect on AbbVie Inc's bipolar disorder drug Depakote that she took while pregnant, in the latest trial among hundreds of lawsuits over the product. |
| |
| | |
